Published online Jul 26, 2023. doi: 10.12998/wjcc.v11.i21.5035
Peer-review started: March 20, 2023
First decision: April 21, 2023
Revised: May 15, 2023
Accepted: June 26, 2023
Article in press: June 26, 2023
Published online: July 26, 2023
The latest health survey in Colombia (ENSIN 2015) found that 37.8% of adults in our country were overweight, while 18.7% were obese. With over half of the population (56.5%) being overweight or obese, this is considered a public health problem in Colombia.
Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a safe and effective procedure for weight loss 2 years post-surgery. SADI-S improves and resolves obesity-related comorbidities. SADI-S has shorter operative time compared to duodenal switch.
The primary objective was to assess the safety of the procedure in terms of intraoperative complications and complications within 30 d postoperatively. The secondary objective was to evaluate weight loss and complications during the follow-up period.
Retrospective data were collected from patients with extreme obesity who underwent laparoscopic SADI-S as a primary or revision procedure after sleeve gastrectomy at Clínica Reina Sofía in Bogotá.
The results of this study support the efficacy and safety of SADI-S as a treatment for extreme obesity.
SADI-S is an effective procedure for patients with extreme obesity. It has a low rate of intraoperative and postoperative complications, with good outcomes in terms of weight loss and improvement/resolution of associated comorbidities. Our experience confirms the reproducibility of the technique when performed in referral centers.
The significance of the study lies in being the first case series published in Spanish-speaking countries in South America, which helps promote the use of this surgery as a viable alternative for patients with extreme obesity, with very low perioperative mortality and good weight loss results up to the observation period.